entresto
novartis europharm limited - sacubitril, valsartan - insuficienta cardiaca - antagoniști ai angiotensinei ii, alte combinații, agenți care acționează asupra sistemului renină-angiotensină - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, valsartan - insuficienta cardiaca - agenți care acționează asupra sistemului renină-angiotensină - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
uperio 24 mg + 26 mg comprimate filmate
novartis pharma services ag - sacubitrilum + enalaprilum - comprimate filmate - 24 mg + 26 mg
uperio 49 mg + 51 mg comprimate filmate
novartis pharma services ag - sacubitrilum + enalaprilum - comprimate filmate - 49 mg + 51 mg
uperio 97 mg + 103 mg comprimate filmate
novartis pharma services ag - sacubitrilum + enalaprilum - comprimate filmate - 97 mg + 103 mg
uperio™ 49 mg/51 mg comprimate filmate
novartis pharma services ag - sacubitrilum + enalaprilum - comprimate filmate - 49 mg/51 mg
uperio™ 24 mg/26 mg comprimate filmate
novartis pharma services ag - sacubitrilum + enalaprilum - comprimate filmate - 24 mg/26 mg
uperio™ 97 mg/103 mg comprimate filmate
novartis pharma services ag - sacubitrilum + enalaprilum - comprimate filmate - 97 mg/103 mg
aqumeldi
proveca pharma limited - enalapril (maleate) - insuficienta cardiaca - agenți care acționează asupra sistemului renină-angiotensină - treatment of heart failure.
hartil amlo 2,5 mg/2,5 mg capsule
egis pharmaceuticals plc - ramiprilum + amlodipinum - capsule - 2,5 mg/2,5 mg